Please use this identifier to cite or link to this item: https://essuir.sumdu.edu.ua/handle/123456789/90081
Or use following links to share this resource in social networks: Recommend this item
Title Торгівля фармацевтичною продукцією в Європейському регіоні: зміни тенденцій під впливом пандемії COVID-19
Other Titles Pharmaceutical products trade in the European region: changing trends under the influence of the COVID-19 pandemic
Authors Letunovska, Nataliia Yevhenivna  
Kashcha, Mariia Oleksiivna  
ORCID http://orcid.org/0000-0001-8207-9178
http://orcid.org/0000-0001-9055-8304
Keywords ризики громадському здоров’ю
risks to public health
зовнішня торгівля
foreign trade
фармацевтичний ринок
pharmaceutical market
криза в система охорони здоров’я
crisis in the health care system
індекс внутрішньогалузевої торгівлі
intra-industry trade index
Type Article
Date of Issue 2022
URI https://essuir.sumdu.edu.ua/handle/123456789/90081
Publisher Ефективна економіка
License Copyright not evaluated
Citation Летуновська Н. Є., Каща М. О. Торгівля фармацевтичною продукцією в Європейському регіоні: зміни тенденцій під впливом пандемії COVID-19 // Ефективна економіка. 2022. № 11. https://doi.org/10.32702/2307-2105.2022.11.35
Abstract У статті досліджені тенденції експортно-імпортних відносин щодо торгівлі фармацевтичною продукцією України, Польщі та Молдови у 2006 -2021 рр. з прогнозуванням індексу внутрішньогалузевої торгівлі в роки постпандемічного відновлення. У ході розрахунків авторами доводиться гіпотеза щодо того, що спалах пандемії COVID-19 має істотний вплив на сферу виробництва та міжнародної торгівлі фармацевтичною продукцією в країнах європейського регіону. Певним чином аналіз експортно-імпортних операцій у цій сфері дає можливість зробити висновки щодо того, чи була економіка країн спроможною в роки пандемії протистояти викликам, спричиненим ризиками громадському здоров’ю. За прогнозами авторів для України можливе посилення загального обсягу внутрішньогалузевої торгівлі як пропорції від загального обсягу торгівлі до 24% у 2026 р. Тоді як для Польщі та Молдови можливі спади, але з поступовим відновленням у тій же п’ятирічній перспективі.
The pharmaceutical industry played a unique role during the COVID-19 pandemic, which was critically important for the prevention and treatment of the disease. It is worth noting that during the global pandemic, trade-in medical goods increased. At the same time, pharmaceutical products accounted for more than half of the world trade in the structure of medical products. From the point of view, comparing the development of the pharmaceutical industry with others and determining the trends of changes in times of crisis in the health care system of the study is relevant. It is noteworthy that the analysis of export-import operations in the field of pharmaceutical production has not been given much attention in scientific research, while this field remains a critically important link in countering the negative consequences of the pandemic and is the parameter that determines the capacity of the national health care system cope with the onslaught of public health risks. The article examines the trends of export-import relations regarding trade in pharmaceutical products of Ukraine, Poland, and Moldova in 2006-2021 with forecasting of the index of intra-industry trade in the years of post-pandemic recovery. In the course of calculations, the authors prove the hypothesis that the outbreak of the COVID-19 pandemic has a significant impact on the sphere of production and international trade of pharmaceutical products in the countries of the European region. To a certain extent, the analysis of export-import transactions in this area makes it possible to conclude whether the economies of countries were able to withstand the challenges caused by public health risks during the pandemic years. According to the authors' forecasts, the total volume of intra-industry trade as a proportion of the total volume of trade may increase to 24% in 2026 for Ukraine, while recessions are possible for Poland and Moldova, but with a gradual recovery in the same five-year perspective. The actual value of the Fisher test was calculated, which makes it possible to conclude the adequacy of the constructed models to confirm the quality of the built forecast models.
The pharmaceutical industry played a unique role during the COVID-19 pandemic, which was critically important for the prevention and treatment of the disease. It is worth noting that during the global pandemic, trade-in medical goods increased. At the same time, pharmaceutical products accounted for more than half of the world trade in the structure of medical products. From the point of view, comparing the development of the pharmaceutical industry with others and determining the trends of changes in times of crisis in the health care system of the study is relevant. It is noteworthy that the analysis of export-import operations in the field of pharmaceutical production has not been given much attention in scientific research, while this field remains a critically important link in countering the negative consequences of the pandemic and is the parameter that determines the capacity of the national health care system cope with the onslaught of public health risks. The article examines the trends of export-import relations regarding trade in pharmaceutical products of Ukraine, Poland, and Moldova in 2006-2021 with forecasting of the index of intra-industry trade in the years of post-pandemic recovery. In the course of calculations, the authors prove the hypothesis that the outbreak of the COVID-19 pandemic has a significant impact on the sphere of production and international trade of pharmaceutical products in the countries of the European region. To a certain extent, the analysis of export-import transactions in this area makes it possible to conclude whether the economies of countries were able to withstand the challenges caused by public health risks during the pandemic years. According to the authors' forecasts, the total volume of intra-industry trade as a proportion of the total volume of trade may increase to 24% in 2026 for Ukraine, while recessions are possible for Poland and Moldova, but with a gradual recovery in the same five-year perspective. The actual value of the Fisher test was calculated, which makes it possible to conclude the adequacy of the constructed models to confirm the quality of the built forecast models.
Appears in Collections: Наукові видання (ННІ БіЕМ)

Views

Austria Austria
11286908
France France
170
Ireland Ireland
118311129
Israel Israel
67718
Russia Russia
40
Singapore Singapore
-1377465797
Ukraine Ukraine
154001631
United Kingdom United Kingdom
4623604
United States United States
1828326901
Unknown Country Unknown Country
1

Downloads

Austria Austria
1835709
China China
4623605
France France
173
Germany Germany
343645847
Indonesia Indonesia
1
Ireland Ireland
1
Israel Israel
1
Ukraine Ukraine
967158381
United States United States
-1377465798

Files

File Size Format Downloads
Letunovska_foreign_trade.pdf 316.98 kB Adobe PDF -60202080

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.